Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended		72 Months Ended
	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2011
Cash flows from operating activities:
Net loss	$ (1,495,607)	$ (3,080,464)	$ (16,352,789)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	14,492	27,690	140,448
Amortization of costs and fees related to convertible debentures	183,904	(26,518)	803,747
Common stock issued for services	42,750	748,663	2,144,790
Common stock issued to officers and directors for services	59,385	554,325	3,078,695
Common stock issued for shares of subsidiary stock	0	0	254,000
Common stock of subsidiary issued to employees and consultants	0	0	2,815
Common stock issued as a commission	0	0	3,000
Common stock issued for accounts payable	18,000	49,018	296,583
Common stock issued to former licensee	0	0	41,319
Common stock issued/recovered on cancelled agreements	0	0	20,478
Non-cash compensation for stock options and warrants	29	67,890	631,923
Costs and fees related to issuance of convertible debt	2,139	634,912	539,252
Interest expense related to beneficial conversion feature	0	0	1,944,800
Interest paid with common stock	13,651	0	118,487
Interest on notes receivable for common stock	0	0	(1,373)
(Increase) decrease in assets:
Prepaid expenses	86,648	(75,069)	25,371
Inventories	90,904	0	0
Notes receivable	0	0	0
Increase (decrease) in liabilities:
Derivative liability	175,865	0	175,865
Trade accounts payable	137,746	233,805	616,544
Accounts payable to officers and directors	182,385	238,237	660,082
Accrued payroll and other expenses	99,274	140,190	261,318
Net cash used in operating activities	(388,435)	(487,321)	(4,594,645)
Cash flows from investing activities:
Net cash used in investing activities	(75,788)	0	(213,142)
Reclassification of fixed assets	(75,788)	0	(213,142)
Cash flows from financing activities:
Principal payments on notes payable to stockholders	0	(60,000)	(1,133,000)
Proceeds from issuance of notes payable to a related party	34,000	92,365	1,039,800
Proceeds from issuance of notes and convertible notes payable	339,869	232,000	1,529,234
Proceeds from issuance of common stock	103,436	212,932	2,181,662
Net cash provided by financing activities	477,305	477,297	3,617,696
Net change in cash	13,082	(10,024)	(1,190,091)
Cash at beginning of period	(7,876)	2,148	1,195,298
Cash at end of period	5,206	(7,876)	5,206
Supplemental Disclosure of Cash Flow Information
Interest paid	664	3,751	10,985
Income taxes paid	1,600	1,600	18,640
Supplemental Schedule of Non-Cash Investing and Financing Activities
Beneficial conversion feature of convertible debentures	0	(6,250)
Common stock issued in consideration for loans	2,139	305,000
Conversion of convertible notes payable to shares of common stock	$ 372,365	$ 0